Prostatic Neoplasms Terminated Phase 3 Trials for Leuprolide (DB00007)

Also known as: Neoplasm,Prostatic / Neoplasms, Prostatic / Prostatic Neoplasm

IndicationStatusPhase
DBCOND0028225 (Prostatic Neoplasms)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00514917A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)Treatment